You just read:

Oxygen Biotherapeutics, Inc. Analyst Report: Positive FDA Catalyst Has Emerging Biopharmaceutical Player Back In the Clinical Trial Business

News provided by

Small Cap Specialists, LLC

Apr 21, 2014, 07:00 ET